After investigating the safety of CAR-T cell drugs, the FDA decided to include a serious risk on the boxed warnings of six approved immunotherapies.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA adds new warning to CAR-T therapies
